A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma

Clinical trial NCT05456256 · RECRUITING

Trial details

NCT number: NCT05456256
Sponsor: Lantern Pharma Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of Lung Carcinoma, Non-Small-Cell Lung

Start date: 2023-03-01
Primary completion: 2026-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.